Sandoz, a subsidiary of Swiss pharmaceutical giant Novartis AG, has agreed to pay US$195 million to avoid trial on charges it conspired to fix the prices of generic drugs, US prosecutors announced on Monday.
The US Department of Justice last year accused Sandoz along with 19 other companies of colluding to artificially inflate the price of about 100 treatments, ranging from non-steroidal anti-inflammatory to drugs for a wide range of diseases.
The price of the treatments multiplied by as much as 10 times, according to the complaint filed in federal court in Connecticut.
“The company agreed to pay a US$195 million criminal penalty and admitted that its sales affected by the charged conspiracies exceeded US$500 million,” the department said in a statement, adding that the misconduct occurred between 2013 and 2015.
“Under the deferred prosecution agreement, Sandoz has agreed to cooperate fully” with the ongoing criminal investigation, it said.
Former Sandoz executive Hector Armando Kellum has pleaded guilty to unspecified charges stemming from the investigation, the department said.
Sandoz had rejected the charges at the time, but on Monday issued a statement admitting “misconduct.”
“We take seriously our compliance with antitrust laws, and in reaching today’s resolution we are not only resolving historical issues, but also underscoring our commitment to continually improving our compliance and training programs, and evolving our controls,” Sandoz president Carol Lynch said.
“We are disappointed that this misconduct occurred in the face of our clear antitrust compliance policies and multiple trainings — and in full contravention of the company’s values,” she said. “Individuals implicated in the underlying conduct are no longer employed by the company.”
Sandoz said it was also negotiating with the department’s civil division to resolve “potential related claims,” and has put aside US$185 million for that.
Other companies accused in the complaint were Israel’s Teva Pharmaceutical Industries Ltd and US-based Mylan Laboratories Inc.
The department said that two other unnamed companies charged in the investigation had reached agreements with prosecutors similar to that accorded to Sandoz, in which prosecution was suspended in exchange for cooperation.
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
CROSS-STRAIT TENSIONS: The US company could switch orders from TSMC to alternative suppliers, but that would lower chip quality, CEO Jensen Huang said Nvidia Corp CEO Jensen Huang (黃仁勳), whose products have become the hottest commodity in the technology world, on Wednesday said that the scramble for a limited amount of supply has frustrated some customers and raised tensions. “The demand on it is so great, and everyone wants to be first and everyone wants to be most,” he told the audience at a Goldman Sachs Group Inc technology conference in San Francisco. “We probably have more emotional customers today. Deservedly so. It’s tense. We’re trying to do the best we can.” Huang’s company is experiencing strong demand for its latest generation of chips, called
GLOBAL ECONOMY: Policymakers have a choice of a small 25 basis-point cut or a bold cut of 50 basis points, which would help the labor market, but might reignite inflation The US Federal Reserve is gearing up to announce its first interest rate cut in more than four years on Wednesday, with policymakers expected to debate how big a move to make less than two months before the US presidential election. Senior officials at the US central bank including Fed Chairman Jerome Powell have in recent weeks indicated that a rate cut is coming this month, as inflation eases toward the bank’s long-term target of two percent, and the labor market continues to cool. The Fed, which has a dual mandate from the US Congress to act independently to ensure